cyclohexanol has been researched along with Breast Cancer in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (60.87) | 29.6817 |
| 2010's | 9 (39.13) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ford, BM; Franks, LN; Prather, PL; Radominska-Pandya, A | 1 |
| Buijs, C; de Jong, RS; de Vries, EG; Marike Boezen, H; Maurer, JM; Mom, CH; Mourits, MJ; Nieboer, P; Willemse, PH; Wymenga, AN | 1 |
| Flockhart, DA; Hayes, DF; Henry, NL; Riba, M; Stearns, V | 1 |
| Barton, DL | 1 |
| Ball, RM; Jakary, S; Kohn, B; Levine, RA; Nunez, R; Pegg, J; Peterson, E; Pocock, JR; Rodriguez, AI; Walker, EM | 1 |
| Amr, YM; Yousef, AA | 1 |
| Doherty, DA; Emery, LI; Gregson, J; Hickey, M; Saunders, CM | 1 |
| Bordeleau, L; Ennis, M; Goodwin, PJ; Haq, R; Jugovic, O; Loprinzi, CL; Pritchard, KI; Warr, D | 1 |
| Adriaansz, S; Beijnen, JH; Boekhout, AH; Dalesio, OB; Foekema-Töns, JH; Nuijen, B; Schellens, JH; Sprangers, S; van den Bosch, J; Vincent, AD | 1 |
| Barton, DL; Loprinzi, CL; Qin, R | 1 |
| Neher, JO; Sarkissian, A; Singh, R; St Anna, L | 1 |
| Gibson-Helm, M; Sayakhot, P; Teede, HJ; Vincent, A | 1 |
| Sleijfer, DT; Wymenga, AN | 1 |
| Goetz, MP; Loprinzi, CL | 1 |
| Stearns, V | 1 |
| Araba, A; Blanchard, R; Desta, Z; Flockhart, DA; Hayden, J; Hayes, DF; Ho, H; Jin, Y; Lee, KH; Lemler, S; Li, L; Nguyen, A; Rae, JM; Skaar, T; Stearns, V; Storniolo, AM; Ullmer, L; Ward, B; Weinshilboum, RM | 1 |
| Bannink, M; Bontenbal, M; Seynaeve, C; van Gool, AR | 1 |
| Biglia, N; Cacciari, F; Kubatzki, F; Maggiorotto, F; Ponzone, R; Roagna, R; Sismondi, P; Torta, R | 1 |
| Azzouz, F; Carpenter, JS; Elam, JL; Johns, S; Johnson, CS; Monahan, PO; Shelton, RC; Storniolo, AM | 1 |
| Kaufmann, M; Loibl, S; Mehta, KM; Schwedler, K; Strohmeier, R; von Minckwitz, G | 1 |
| Barton, DL; Christensen, BJ; Dakhil, SR; Kugler, JW; LaVasseur, BI; Loprinzi, CL; Mailliard, JA; Novotny, PJ; Rodger, K; Rummans, TA; Sloan, JA | 1 |
| Härtel, B; Kalso, E; Tasmuth, T | 1 |
5 review(s) available for cyclohexanol and Breast Cancer
| Article | Year |
|---|---|
Drug interactions and pharmacogenomics in the treatment of breast cancer and depression.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antineoplastic Agents, Hormonal; Biotransformation; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Delayed-Action Preparations; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Genotype; Hot Flashes; Humans; Middle Aged; Pharmacogenetics; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Clinical Inquiry: Do venlafaxine and gabapentin control hot flashes in women with a history of breast cancer?
Topics: Amines; Anti-Anxiety Agents; Breast Neoplasms; Constipation; Cyclohexanecarboxylic Acids; Cyclohexanols; Dizziness; Dose-Response Relationship, Drug; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Off-Label Use; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2012 |
Management of hot flushes in breast cancer patients.
Topics: Adrenergic alpha-Agonists; Breast Neoplasms; Cyclohexanols; Female; Hot Flashes; Humans; Megestrol Acetate; Venlafaxine Hydrochloride | 2002 |
A hot flash on tamoxifen metabolism.
Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cyclohexanols; Cytochrome P-450 CYP2D6; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Fluoxetine; Hot Flashes; Humans; Hydroxylation; Paroxetine; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Venlafaxine Hydrochloride | 2003 |
Management of hot flashes in breast cancer survivors and men with prostate cancer.
Topics: Amines; Anti-Anxiety Agents; Breast Neoplasms; Complementary Therapies; Contraceptives, Oral, Synthetic; Cyclohexanecarboxylic Acids; Cyclohexanols; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Male; Medroxyprogesterone; Menopause, Premature; Paroxetine; Prostatic Neoplasms; Quality of Life; Selective Serotonin Reuptake Inhibitors; Survivors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
10 trial(s) available for cyclohexanol and Breast Cancer
| Article | Year |
|---|---|
Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study.
Topics: Adrenergic alpha-Agonists; Adult; Breast Neoplasms; Clonidine; Cross-Over Studies; Cyclohexanols; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial.
Topics: Acupuncture Therapy; Adult; Aged; Analgesics; Antidepressive Agents, Second-Generation; Breast Neoplasms; Cyclohexanols; Estrogen Replacement Therapy; Female; Follow-Up Studies; Hot Flashes; Humans; Middle Aged; Postmenopause; Prognosis; Quality of Life; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Evaluation of efficacy of the perioperative administration of Venlafaxine or gabapentin on acute and chronic postmastectomy pain.
Topics: Acute Disease; Adult; Amines; Analgesics; Breast Neoplasms; Chronic Disease; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Mastectomy, Radical; Mastectomy, Segmental; Middle Aged; Morphine; Pain Measurement; Pain, Postoperative; Perioperative Care; Statistics, Nonparametric; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors.
Topics: Amines; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Breast Neoplasms; Cross-Over Studies; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Middle Aged; Patient Preference; Surveys and Questionnaires; Survivors; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Analgesics; Breast Neoplasms; Clonidine; Cyclohexanols; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Placebos; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
Evaluation of low-dose venlafaxine hydrochloride for the therapy of hot flushes in breast cancer survivors.
Topics: Adolescent; Adult; Breast Neoplasms; Cyclohexanols; Drug Administration Schedule; Female; Hot Flashes; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Survivors; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.
Topics: Adult; Breast Neoplasms; Cyclohexanols; Disease-Free Survival; Double-Blind Method; Female; Hot Flashes; Humans; Placebos; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.
Topics: Adult; Aged; Breast Neoplasms; Clonidine; Cyclohexanols; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2007 |
Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial.
Topics: Antidepressive Agents, Second-Generation; Breast Neoplasms; Cyclohexanols; Double-Blind Method; Female; Hot Flashes; Humans; Venlafaxine Hydrochloride | 2000 |
Venlafaxine in neuropathic pain following treatment of breast cancer.
Topics: Analgesics; Breast Neoplasms; Cross-Over Studies; Cyclohexanols; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Female; Humans; Mastectomy; Neuralgia; Pain Measurement; Peripheral Nervous System Diseases; Postoperative Complications; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
8 other study(ies) available for cyclohexanol and Breast Cancer
| Article | Year |
|---|---|
Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development.
Topics: Adenylyl Cyclases; Animals; Binding, Competitive; Breast Neoplasms; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; Cyclohexanols; Female; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Indoles; Isomerism; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Selective Estrogen Receptor Modulators; Tamoxifen | 2016 |
Menopausal symptoms following tamoxifen treatment for breast cancer.
Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclohexanols; Female; Hot Flashes; Humans; Menopause; Middle Aged; Relaxation Therapy; Tamoxifen; Venlafaxine Hydrochloride | 2008 |
The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care Facilities; Amines; Anti-Anxiety Agents; Breast Neoplasms; Clonidine; Cyclohexanecarboxylic Acids; Cyclohexanols; Fatigue; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Libido; Menopause; Middle Aged; Patient Care Team; Patient Education as Topic; Patient Satisfaction; Patient-Centered Care; Practice Guidelines as Topic; Referral and Consultation; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Sweating; Sympatholytics; Venlafaxine Hydrochloride; Vitamin E; Vitamins | 2010 |
Nonestrogenic management of hot flashes.
Topics: Breast Neoplasms; Clonidine; Cyclohexanols; Female; Hot Flashes; Humans; Venlafaxine Hydrochloride | 2011 |
Differences in clinician understanding and management of early menopause after breast cancer.
Topics: Anxiety; Australia; Breast Neoplasms; Cross-Sectional Studies; Cyclohexanols; Depression; Endocrinology; Exercise; Female; Follicle Stimulating Hormone; General Practitioners; General Surgery; Gynecology; Hot Flashes; Humans; Life Style; Medical Oncology; Menopause, Premature; Practice Patterns, Physicians'; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2013 |
CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Aryl Hydrocarbon Hydroxylases; Arylsulfotransferase; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclohexanols; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Administration Schedule; Enzyme Inhibitors; Estrogen Receptor Modulators; Female; Genotype; Humans; Middle Aged; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Time Factors; Venlafaxine Hydrochloride | 2005 |
Clinical experience with venlafaxine in the treatment of hot flushes in women with a history of breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Cyclohexanols; Female; Follow-Up Studies; Hot Flashes; Humans; Middle Aged; Retrospective Studies; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Breast cancer and hot flashes. Options for relief.
Topics: Breast Neoplasms; Cyclohexanols; Female; Hot Flashes; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2001 |